BOT 6.25% 34.0¢ botanix pharmaceuticals ltd

Ann: BTX 1702 Rosacea Study Approval, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 273 Posts.
    lightbulb Created with Sketch. 191

    agreed a product approval is some time away, but I like this line in the Ann-

    ’Botanix also continues to assess complementary opportunities and partnerships for dermatology and antimicrobials products that can be rapidly brought to market which leverage the Company’s broad management experience capability and experience.’

    i may be reading into this too much, but does the word ‘assess’ when talking about partnerships mean they have opportunities on the table? If not, wouldn’t they use the term ‘look for’ or ‘pursue’ rather than assess? Just a thought, IMO there may be a partnership announcement in the not too distant future. Dyor
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.020(6.25%)
Mkt cap ! $617.9M
Open High Low Value Volume
32.5¢ 34.3¢ 32.5¢ $1.814M 5.424M

Buyers (Bids)

No. Vol. Price($)
6 489055 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 340303 4
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.